{"podcast":{"title":"632nm","slug":"632nm-6933948","podcast_index_feed_id":6933948,"rss_url":"https://feeds.transistor.fm/632nm","website_url":"https://632nm.com","image_url":"https://img.transistorcdn.com/nEXmi7A5la3DaXHPICs5XCc9TDmVySH0knUXP1bJgUk/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8yOGMz/YTliMThlODIyYzYw/OGVjOWNiZWNlNmQ1/ZmQ0Ni5qcGc.jpg","author":"Misha Shalaginov, Michael Dubrovsky, Xinghui Yin","episode_count":58,"summary":"Technical interviews with the greatest scientists in the world.","last_synced_at":"2026-09-09T06:19:48.668776+00:00","page_url":"https://stenobird.com/podcast/632nm-6933948"},"episode":{"title":"Inside the Battle for Psychedelic Therapy | Rick Doblin","slug":"inside-the-battle-for-psychedelic-therapy-rick-doblin","published_at":"2025-08-26T15:00:00+00:00","page_url":"https://stenobird.com/podcast/632nm-6933948/inside-the-battle-for-psychedelic-therapy-rick-doblin","show_page_url":"https://stenobird.com/podcast/632nm-6933948","url":"https://share.transistor.fm/s/dbc63676","audio_url":"https://media.transistor.fm/dbc63676/0793b765.mp3","summary":"What does it take to turn a banned psychedelic into an FDA-approved medicine? Visit MAPS to read about the latest progress is psychedelic research: https://maps.org/ In this episode, we speak with Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies (MAPS), about the decades-long mission to make MDMA-assisted therapy a legal treatment for PTSD and other mental health conditions. Rick received his PhD from Harvard's Kennedy School of Government in public policy focusing on the regulation of medical use of psychedelics in 2001. Rick shares the science behind MDMA’s therapeutic effects, the strategy for winning over regulators, and the battles over claims of neurotoxicity. We discuss the history of psychedelic research, the rise of the underground therapy movement, and how clinical trials, policy change, and cultural perception must align to move psychedelics from stigma to science. Whether you’re curious about psychedelic science, drug policy reform, FDA clinical trials, or the future of mental health treatment, this conversation delivers expert insight into the intersection of research, regulation, and real-world impact. Follow us for more technical interviews with the world’s greatest scientists: Twitter: https://x.com/632nmPodcast Instagram: https://www.instagram.com/632nmpodcast?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw== LinkedIn: https://www.linkedin.com/company/632nm/about/ Substack: https://632nmpodcast.substack.com/ Follow our hosts! Michael Dubrovsky: https://x.com/MikeDubrovsky Misha Shalaginov: https://x.com/MYShalaginov Xinghui Yin: https://x.com/XinghuiYin Subscribe: Apple Podcasts: https://podcasts.apple.com/us/podcast/632nm/id1751170269 Spotify: https://open.spotify.com/show/4aVH9vT5qp5UUUvQ6Uf6OR Website: […","meta_description":"What does it take to turn a banned psychedelic into an FDA-approved medicine? Visit MAPS to read about the latest progress is psychedelic research: https:…","key_points":[],"chapters":[],"topics":[],"duration_seconds":9482,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/632nm-6933948/episodes/inside-the-battle-for-psychedelic-therapy-rick-doblin/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/632nm-6933948/inside-the-battle-for-psychedelic-therapy-rick-doblin.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}